Ceeto Capital Group’s Pfizer PFE Stock Holding History

Ceeto Capital Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28M	Sell	53,250 -5,000	-9%	-$131K	0.35%	69
2026 Q1	$1.64M	Hold	58,250	–	–	0.5%	49
2025 Q4	$1.45M	Sell	58,250 -8,000	-12%	-$202K	0.42%	50
2025 Q3	$1.69M	Hold	66,250	–	–	0.49%	43
2025 Q2	$1.61M	Buy	66,250 +11,000	+20%	+$257K	0.56%	41
2025 Q1	$1.4M	Hold	55,250	–	–	0.53%	41
2024 Q4	$1.47M	Sell	55,250 -2,000	-3%	-$54.3K	0.54%	39
2024 Q3	$1.66M	Buy	57,250 +500	+0.9%	+$14.6K	0.62%	35
2024 Q2	$1.59M	Buy	56,750 +14,500	+34%	+$399K	0.62%	39
2024 Q1	$1.17M	Buy	42,250 +1,000	+2%	+$27.7K	0.48%	49
2023 Q4	$1.19M	Buy	41,250 +750	+2%	+$22.7K	0.51%	46
2023 Q3	$1.34M	Buy	40,500 +1,500	+4%	+$53K	0.65%	40
2023 Q2	$1.43M	Hold	39,000	–	–	0.66%	38
2023 Q1	$1.59M	Buy	39,000 +6,000	+18%	+$259K	0.79%	32
2022 Q4	$1.69M	Hold	33,000	–	–	0.93%	26
2022 Q3	$1.44M	Hold	33,000	–	–	0.83%	31
2022 Q2	$1.73M	Sell	33,000 -5,000	-13%	-$255K	0.95%	23
2022 Q1	$1.97M	Sell	38,000 -5,831	-13%	-$303K	0.9%	27
2021 Q4	$2.59M	Hold	43,831	–	–	1.08%	15
2021 Q3	$1.89M	Buy	43,831 +5,000	+13%	+$222K	0.88%	26
2021 Q2	$1.52M	Hold	38,831	–	–	0.69%	42
2021 Q1	$1.41M	Buy	38,831 +14,500	+60%	+$515K	0.69%	44
2020 Q4	$896K	Sell	24,331 -1,314	-5%	-$48.2K	0.45%	62
2020 Q3	$893K	Hold	25,645	–	–	0.5%	57
2020 Q2	$796K	Buy	25,645 +775	+3%	+$26.3K	0.52%	57
2020 Q1	$770K	Buy	24,870 +806	+3%	+$27.5K	0.62%	51
2019 Q4	$895K	Hold	24,064	–	–	0.59%	52
2019 Q3	$820K	Hold	24,064	–	–	0.59%	54
2019 Q2	$989K	Hold	24,064	–	–	0.73%	43
2019 Q1	$970K	Hold	24,064	–	–	0.71%	47
2018 Q4	$997K	Hold	24,064	–	–	0.82%	40
2018 Q3	$1.01M	Hold	24,064	–	–	0.69%	51
2018 Q2	$828K	Hold	24,064	–	–	0.62%	55
2018 Q1	$810K	Hold	24,064	–	–	0.61%	58
2017 Q4	$827K	Hold	24,064	–	–	0.59%	59
2017 Q3	$815K	Buy	+24,064	New	+$773K	0.61%	54

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ceeto Capital Group's PFE Position: Q2 2026 in Review

Ceeto Capital Group reduced its Pfizer (PFE) stake by 8.6% in Q2 2026, selling an estimated $131K and leaving 53,250 shares worth $1.28M. The position accounts for 0.35% of the portfolio, ranked #69.

Ceeto Capital Group first reported a position in PFE in Q3 2017 and has held it in 36 quarters since. The position peaked at $2.59M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Ceeto Capital Group held 53,250 shares of Pfizer worth $1.28M as of Q2 2026.
Ceeto Capital Group sold 5,000 Pfizer shares in Q2 2026, an estimated $131K.
Pfizer made up 0.35% of Ceeto Capital Group's portfolio in Q2 2026, its #69 holding.
Ceeto Capital Group first reported a position in Pfizer in Q3 2017 and has held it in 36 quarters since.
Ceeto Capital Group's Pfizer position peaked at $2.59M in Q4 2021.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ceeto Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.